Old and New Therapeutic Strategies in Children with Liver Disease

A special issue of Children (ISSN 2227-9067).

Deadline for manuscript submissions: closed (30 September 2024) | Viewed by 322

Special Issue Editors


E-Mail Website
Guest Editor
Department of Translational Medical Science, Section of Pediatrics, University of Naples Federico II, 80131 Naples, Italy
Interests: hepatitis; children; cholestasis; cirrhosis; liver; Wilson disease; liver steatosis

E-Mail Website
Guest Editor
Department of Translational Medical Science, Section of Pediatrics, University of Naples Federico II, 80131 Naples, Italy
Interests: pediatric liver disease

Special Issue Information

Dear Colleagues,

We are pleased to present this Special Issue of Children: ‘Old and new therapeutic strategies in children with liver disease’. As Guest Editors of this issue, we look forward to collaborating with experts on topics of great importance to the pediatric community. Liver disease has always been a public health problem with few treatment options, particularly for cholestatic disorders. The topic has recently become very important due to advances in therapeutic strategies. New drugs have also been proposed that can change the outcome of some chronic liver diseases that sometimes require liver transplants. This Special Issue aims to provide an update on the old and new drugs for liver diseases and give an overview of the main currently available therapeutic strategies. Original articles and narrative or systematic reviews are welcome.

Dr. Raffaele Iorio
Dr. Fabiola Di Dato
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pediatric liver disease
  • acetaminophen
  • ibat
  • UDCA
  • steroids
  • cholestasis
  • rifampicin

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop